Medical News

RSS

QRxPharma initiates Phase 1 trial for evaluating PK profiles of morphine, oxycodone CR formulations

QRxPharma announced today initiation of the Company's first Phase 1 trial to evaluate the pharmacokinetic (PK) profiles of experimental controlled-release (CR) morphine and oxycodone formulations that will be incorporated into MoxDuo®CR. MoxDuo®CR contains a fixed 3:2 morphine:oxycodone combination and is intended to be dosed twice daily in patients experiencing chronic pain, an approximately US$7 billion dollar market worldwide.

31 Mar 2010

United Anesthesia Services deploys Quantum Clinical Navigation System in Bryn Mawr Hospital

United Anesthesia Services, P.C. has taken the lead in the Pennsylvania marketplace regarding its commitment to patient quality by deploying the Quantum Clinical Navigation System™ in Bryn Mawr Hospital.

31 Mar 2010

Vision CRC scientists discover new technology to control myopia

Scientists from the Vision Cooperative Research Centre in Australia today announced that myopia, or short-sightedness, can be controlled with new technology. This ground breaking discovery was based on research conducted by Vision CRC partners - the University of Houston College of Optometry and the Brien Holden Vision Institute, located at the University of New South Wales.

31 Mar 2010

Close-ups on how the health overhaul gives and takes away

"An association representing 300 large corporations urged President Obama and Congress on Monday to repeal a provision of the health care overhaul that prompted AT&T, Caterpillar and other companies to announce substantial charges for the current quarter."

31 Mar 2010

Asclera injection receives FDA approval

The U.S. Food and Drug Administration today approved Asclera (polidocanol) injection for the treatment of small types of abnormally swollen or twisted veins called varicose veins.

31 Mar 2010

YM BioSciences receives approval to expand enrolment in Phase I/II clinical trial of CYT387

YM BioSciences Inc., announced that it has received ethics board approval to expand enrolment in its Phase I/II clinical trial of CYT387 at Mayo Clinic in patients with myelofibrosis, a chronic debilitating condition, where patient's bone marrow is replaced by scar tissue.

31 Mar 2010

Facts and treatment options for endometriosis

One out of every two women struggling to conceive may suffer from endometriosis - the leading cause of infertility - according to research from Camran Nezhat, M.D., gynecologist at El Camino Hospital, the hospital of the Silicon Valley.

31 Mar 2010

States mull joining health care reform lawsuits or keeping out of it

The Associated Press/New York Times: Indiana has joined the lawsuit brought by 13 states challenging the constitutionality of a mandate on Americans to carry health insurance in the new health reform law. "State Attorney General Greg Zoeller said Monday that Indiana would be added to an amended version of the lawsuit against the law that is expected to be filed soon" (3/29).

31 Mar 2010

ZeOmega to achieve CMMI Level 3 certification

ZeOmega is pleased to announce that it is the first Care Management software vendor to achieve CMMI Level 3 certification. This globally recognized standard, which is also sought after by major software companies worldwide, signals ZeOmega's commitment to consistently deliver high quality and reliable care management software and related services.

31 Mar 2010

FDA issues Complete Response Letter for CERTRIAD NDA

AstraZeneca and Abbott announced today that the U.S. Food and Drug Administration (FDA) issued a complete response letter (CRL) for the New Drug Application (NDA) for CERTRIAD™ (rosuvastatin / fenofibric acid delayed release) Capsules.

31 Mar 2010

Women, diabetics, dementia patients most likely to fall in 'doughnut hole'; Reform seeks to close coverage gap

Among elderly Americans, women and those with diabetes and dementia are most likely to find themselves in the Medicare Part D drug plan 'doughnut hole,' the coverage gap that occurs after a beneficiary has reached the annual coverage limit but hasn't spent enough on drugs to qualify for catastrophic coverage.

31 Mar 2010

Access Pharmaceuticals, bioRASI sign collaborative agreement to develop Cobalamin oral insulin product

ACCESS PHARMACEUTICALS, INC. signed a collaborative development agreement with bioRASI, LLC, a full-service global CRO specializing in the accelerated development of novel therapeutics, to facilitate clinical development for its Cobalamin™-based oral insulin and other Cobalamin-based products.

31 Mar 2010

Despite simmering GOP rage on health bill, some Republicans say they can still work with Democrats

NPR reports: "Though conservative anger with Washington over the newly signed bill has been particularly hot, some longtime political observers see a revival of previous populist movements from the right. ... Chip Berlet with Political Research Associates, a liberal group that tracks populist anti-government movements, says this is nothing new.

31 Mar 2010

Titan Pharmaceuticals commences Phase 3 study of Probuphine for opioid addiction

Titan Pharmaceuticals, Inc. today announced the initiation of a randomized, placebo and active controlled, multi-center Phase 3 clinical study of Probuphine in the treatment of opioid addiction. This confirmatory Phase 3 study will be conducted at approximately 23 sites in the United States and randomize approximately 250 patients into three arms: Probuphine (100 patients), Suboxone® (100 patients) and placebo (50 patients).

31 Mar 2010

Ikaria Holdings acquires NDA and IND application for LUCASSIN drug

Ikaria Holdings, Inc. announced today that it has acquired the New Drug Application (NDA) and the Investigational New Drug (IND) application to LUCASSIN® (terlipressin for injection) from Orphan Therapeutics, assuming all future development and ownership of the drug in North America and Australia.

31 Mar 2010

Coastal Contacts announces loan agreement with Bank of America

Coastal Contacts Inc. today announced that it has entered into a loan agreement with the Bank of America for a $5 million secured revolving line of credit.

31 Mar 2010

Hospira acquires Orchid's injectables formulations business

Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced it has completed the acquisition of the generic injectable pharmaceuticals business of Orchid Chemicals & Pharmaceuticals Ltd., a leading Indian pharmaceuticals company, for approximately $400 million.

31 Mar 2010

SpineAlign Medical announces VerteLift as new name for vertebral implant system

SpineAlign Medical Inc. announced today that it has chosen a new trademark name, VerteLift, for its vertebral implant system. Formerly called the SpineAlign System, the name reflects the advantages of the product that the Company will leverage going forward.

30 Mar 2010

MedeAnalytics' white paper focuses on potential reductions of annual updates to the IPPS

MedeAnalytics, a leading provider of healthcare performance management solutions, today released a white paper on one of the HITECH Act's measures designed to motivate hospitals to become meaningful users of electronic health records (EHRs): potential negative adjustments to Medicare's market basket updates to the Inpatient Prospective Payment System (IPPS).

30 Mar 2010

CLC bio signs partnership agreement with Ion Torrent

CLC bio, the world's leading bioinformatics solution provider, today announced a partnership with Ion Torrent, a new sequencing company started by Dr. Jonathan Rothberg, the founder of 454 Life Sciences. The partnership will ensure that data can directly flow off of the Ion Personal Genome Machine sequencer and into CLC bio's solutions, like CLC Genomics Workbench or CLC Genomics Server.

30 Mar 2010

Medical News

QRxPharma initiates Phase 1 trial for evaluating PK profiles of morphine, oxycodone CR formulations

United Anesthesia Services deploys Quantum Clinical Navigation System in Bryn Mawr Hospital

Vision CRC scientists discover new technology to control myopia

Close-ups on how the health overhaul gives and takes away

Asclera injection receives FDA approval

YM BioSciences receives approval to expand enrolment in Phase I/II clinical trial of CYT387

Facts and treatment options for endometriosis

States mull joining health care reform lawsuits or keeping out of it

ZeOmega to achieve CMMI Level 3 certification

FDA issues Complete Response Letter for CERTRIAD NDA

Women, diabetics, dementia patients most likely to fall in 'doughnut hole'; Reform seeks to close coverage gap

Access Pharmaceuticals, bioRASI sign collaborative agreement to develop Cobalamin oral insulin product

Despite simmering GOP rage on health bill, some Republicans say they can still work with Democrats

Titan Pharmaceuticals commences Phase 3 study of Probuphine for opioid addiction

Ikaria Holdings acquires NDA and IND application for LUCASSIN drug

Coastal Contacts announces loan agreement with Bank of America

Hospira acquires Orchid's injectables formulations business

SpineAlign Medical announces VerteLift as new name for vertebral implant system

MedeAnalytics' white paper focuses on potential reductions of annual updates to the IPPS

CLC bio signs partnership agreement with Ion Torrent

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News